Nanomedicine QC and Stability Testing

GMP-aligned analytics, ICH stability programs and batch-release testing—built around CMAs, CQAs and long-term product performance.

MyBiotech provides comprehensive Quality Control and stability testing services to ensure full understanding and control of critical material attributes (CMAs), critical quality attributes (CQAs) and long-term stability of nanoparticle drug products. Our analytical approach supports development, clinical manufacturing and regulatory submissions with phase-appropriate, ICH-compliant and GMP-aligned validation strategies. Using robust methods and clear specifications, we enable comparability, data trending and confident release decisions.

Advanced Quality Control

All analytical activities follow fit-for-phase approaches aligned with ICH expectations and GMP principles. Our QC laboratory provides broad analytical expertise including advanced chromatography, dissolution testing, Karl Fischer titration and validated GMP analytical methods—supporting method lifecycle management from development through clinical supply.

1 Routine characterization of raw materials and finished products

2 In-process testing and Quality Control during manufacturing

3 ICH-compliant stability testing

4 Identity, assay (quantitative), and limit tests

5 Impurity profiling and forced-degradation studies

6 Analysis according to Ph. Eur., USP, and other monographs

7 Analytical method development and validation

8 Advanced characterization for unconventional raw materials and finished products

9 GMP-compliant testing, documentation, and batch-release certification

Nanomedicine QC and Stability Testing

GMP-aligned analytics, ICH stability programs and batch-release testing—built around CMAs, CQAs and long-term product performance.

Advanced Quality Control

1

Routine characterization of raw materials and finished products

2

In-process testing and Quality Control during manufacturing

3

ICH-compliant stability testing

4

Identity, assay (quantitative), and limit tests

5

Impurity profiling and forced-degradation studies

6

Analysis according to Ph. Eur., USP, and other monographs

7

Analytical method development and validation

8

Advanced characterization for unconventional raw materials and finished products

9

GMP-compliant testing, documentation, and batch-release certification

CDMO EXPERTS in Nanomedicine

Site Notice

Privacy Policy

Disclaimer